17 Sep 2025 | 3 Mins Read
Lupin hit after USFDA flags Nagpur facility with six observations
Flipitmoney
Lupin shares are in focus on September 17 after the USFDA issued six observations for the company's Nagpur injectable facility following a September 8-16 inspection. Lupin will address the observations and the stock has gained 4% in the past month, but is 13.2% down this year. Its Risperidone Injectable gained USFDA approval earlier this month.